These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21967521)

  • 21. Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping.
    Madden HR; Fletcher S; Davis MR; Wilton SD
    Hum Mutat; 2009 Jan; 30(1):22-8. PubMed ID: 18570328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.
    Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M
    Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for x-linked dilated cardiomyopathy.
    Rimessi P; Fabris M; Bovolenta M; Bassi E; Falzarano S; Gualandi F; Rapezzi C; Coccolo F; Perrone D; Medici A; Ferlini A
    Hum Gene Ther; 2010 Sep; 21(9):1137-46. PubMed ID: 20486769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice.
    Yang L; Niu H; Gao X; Wang Q; Han G; Cao L; Cai C; Weiler J; Yin H
    PLoS One; 2013; 8(4):e61584. PubMed ID: 23658612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric RNA and 2'-O, 4'-C-ethylene-bridged nucleic acids have stronger activity than phosphorothioate oligodeoxynucleotides in induction of exon 19 skipping in dystrophin mRNA.
    Yagi M; Takeshima Y; Surono A; Takagi M; Koizumi M; Matsuo M
    Oligonucleotides; 2004; 14(1):33-40. PubMed ID: 15104894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exon skipping therapy for Duchenne muscular dystrophy.
    Kole R; Krieg AM
    Adv Drug Deliv Rev; 2015 Jun; 87():104-7. PubMed ID: 25980936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy.
    Dwianingsih EK; Malueka RG; Nishida A; Itoh K; Lee T; Yagi M; Iijima K; Takeshima Y; Matsuo M
    J Hum Genet; 2014 Aug; 59(8):423-9. PubMed ID: 24871807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational design of antisense oligomers to induce dystrophin exon skipping.
    Mitrpant C; Adams AM; Meloni PL; Muntoni F; Fletcher S; Wilton SD
    Mol Ther; 2009 Aug; 17(8):1418-26. PubMed ID: 19293776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.
    Wilton SD; Lloyd F; Carville K; Fletcher S; Honeyman K; Agrawal S; Kole R
    Neuromuscul Disord; 1999 Jul; 9(5):330-8. PubMed ID: 10407856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terminal antisense oligonucleotide modifications can enhance induced exon skipping.
    Gebski BL; Errington SJ; Johnsen RD; Fletcher S; Wilton SD
    Neuromuscul Disord; 2005 Oct; 15(9-10):622-9. PubMed ID: 16084084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renadirsen, a Novel 2'OMeRNA/ENA
    Ito K; Takakusa H; Kakuta M; Kanda A; Takagi N; Nagase H; Watanabe N; Asano D; Goda R; Masuda T; Nakamura A; Onishi Y; Onoda T; Koizumi M; Takeshima Y; Matsuo M; Takaishi K
    Curr Issues Mol Biol; 2021 Sep; 43(3):1267-1281. PubMed ID: 34698059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides.
    Dunckley MG; Manoharan M; Villiet P; Eperon IC; Dickson G
    Hum Mol Genet; 1998 Jul; 7(7):1083-90. PubMed ID: 9618164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript.
    Wilton SD; Fall AM; Harding PL; McClorey G; Coleman C; Fletcher S
    Mol Ther; 2007 Jul; 15(7):1288-96. PubMed ID: 17285139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures.
    Hiller M; Falzarano MS; Garcia-Jimenez I; Sardone V; Verheul RC; Popplewell L; Anthony K; Ruiz-Del-Yerro E; Osman H; Goeman JJ; Mamchaoui K; Dickson G; Ferlini A; Muntoni F; Aartsma-Rus A; Arechavala-Gomeza V; Datson NA; Spitali P
    PLoS One; 2018; 13(10):e0204485. PubMed ID: 30278058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons.
    Aartsma-Rus A; Kaman WE; Weij R; den Dunnen JT; van Ommen GJ; van Deutekom JC
    Mol Ther; 2006 Sep; 14(3):401-7. PubMed ID: 16753346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of antisense oligonucleotide length on dystrophin exon skipping.
    Harding PL; Fall AM; Honeyman K; Fletcher S; Wilton SD
    Mol Ther; 2007 Jan; 15(1):157-66. PubMed ID: 17164787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides.
    Aartsma-Rus A; Janson AA; Heemskerk JA; De Winter CL; Van Ommen GJ; Van Deutekom JC
    Ann N Y Acad Sci; 2006 Oct; 1082():74-6. PubMed ID: 17145928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
    Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
    Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of 2'-O-Me RNA/ENA chimera oligonucleotides to induce exon skipping in dystrophin pre-mRNA.
    Takagi M; Yagi M; Ishibashi K; Takeshima Y; Surono A; Matsuo M; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):297-8. PubMed ID: 17150596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH; Sirsi SR; Latta DR; Lutz GJ
    Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.